Risk factors for anastomotic leakage after colorectal resection in ovarian cancer surgery: A multi-centre study.


Journal

Gynecologic oncology
ISSN: 1095-6859
Titre abrégé: Gynecol Oncol
Pays: United States
ID NLM: 0365304

Informations de publication

Date de publication:
06 2019
Historique:
received: 22 02 2019
revised: 14 03 2019
accepted: 15 03 2019
pubmed: 7 4 2019
medline: 14 8 2019
entrez: 7 4 2019
Statut: ppublish

Résumé

To determine pre-/intraoperative risk factors for anastomotic leak after modified posterior pelvic exenteration (MPE) or colorectal resection in ovarian cancer and to create a practical instrument for predicting anastomotic leak risk. In advanced ovarian cancer surgery, there is rather limited published evidence, drawn from a small sample, providing information about risk factors for anastomotic leak. Eight hospitals participated in this retrospective study. Data on 695 patients operated for ovarian cancer with primary anastomosis were included (January 2010-June 2018). Twelve pre-/intraoperative variables were analysed as potential independent risk factors for anastomotic leak. A predictive model was created to stablish the risk of anastomotic leak for a given patient. The anastomotic leak rate was 6.6% (46/695; range 1.7%-12.5%). A total of 457 patients were included in the final multivariate analysis. The following variables were found to be independently associated with anastomotic leakage: age at surgery (OR 1.046, 95% CI 1.013-1.080, p = 0.005), serum albumin level (OR 0.621, 95% CI 0.407-0.948, p = 0.027), one or more additional small bowel resections (OR 3.544, 95% CI 1.228-10.23, p = 0.019), manual anastomosis (OR 8.356, 95% CI 1.777-39.301, p = 0.007) and distance of the anastomosis from the anal verge (OR 0.839, 95% CI 0.726-0.971, p = 0.018). Due to the low incidence of AL in ovarian cancer patients, a restrictive stoma policy based on the presence of risk factors should be the actual recommendation. Hand-sewn anastomosis should be avoided.

Sections du résumé

OBJECTIVE
To determine pre-/intraoperative risk factors for anastomotic leak after modified posterior pelvic exenteration (MPE) or colorectal resection in ovarian cancer and to create a practical instrument for predicting anastomotic leak risk.
BACKGROUND
In advanced ovarian cancer surgery, there is rather limited published evidence, drawn from a small sample, providing information about risk factors for anastomotic leak.
METHODS
Eight hospitals participated in this retrospective study. Data on 695 patients operated for ovarian cancer with primary anastomosis were included (January 2010-June 2018). Twelve pre-/intraoperative variables were analysed as potential independent risk factors for anastomotic leak. A predictive model was created to stablish the risk of anastomotic leak for a given patient.
RESULTS
The anastomotic leak rate was 6.6% (46/695; range 1.7%-12.5%). A total of 457 patients were included in the final multivariate analysis. The following variables were found to be independently associated with anastomotic leakage: age at surgery (OR 1.046, 95% CI 1.013-1.080, p = 0.005), serum albumin level (OR 0.621, 95% CI 0.407-0.948, p = 0.027), one or more additional small bowel resections (OR 3.544, 95% CI 1.228-10.23, p = 0.019), manual anastomosis (OR 8.356, 95% CI 1.777-39.301, p = 0.007) and distance of the anastomosis from the anal verge (OR 0.839, 95% CI 0.726-0.971, p = 0.018).
CONCLUSIONS
Due to the low incidence of AL in ovarian cancer patients, a restrictive stoma policy based on the presence of risk factors should be the actual recommendation. Hand-sewn anastomosis should be avoided.

Identifiants

pubmed: 30952369
pii: S0090-8258(19)30434-2
doi: 10.1016/j.ygyno.2019.03.241
pii:
doi:

Substances chimiques

Serum Albumin 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Pagination

549-554

Informations de copyright

Crown Copyright © 2019. Published by Elsevier Inc. All rights reserved.

Auteurs

V Lago (V)

Department of Gynecologic Oncology Department, University Hospital La Fe, Valencia, Spain. Electronic address: victor.lago.leal@hotmail.com.

C Fotopoulou (C)

Department of Gynecologic Oncology, Imperial College London, London, United Kingdom.

V Chiantera (V)

Department of Gynecologic Oncology, University of Palermo, Palermo, Italy.

L Minig (L)

Department of Gynecology, CEU Cardenal Herrera University, Valencia, Spain.

A Gil-Moreno (A)

Department of Obstetrics and Gynecology, Vall d'Hebron, Barcelona, Spain.

P A Cascales-Campos (PA)

Department of General Surgery, Virgen de la Arrixaca Clinic and University Hospital, Murcia, Spain.

M Jurado (M)

Department of Obstetrics and Gynecology, University Clinic of Navarra, Navarre, Spain.

A Tejerizo (A)

Department of Obstetrics and Gynecology, Hospital 12 de Octubre, Madrid, Spain.

P Padilla-Iserte (P)

Department of Gynecologic Oncology Department, University Hospital La Fe, Valencia, Spain.

M E Malune (ME)

Department of Gynecologic Oncology, Imperial College London, London, United Kingdom.

M C Di Donna (MC)

Department of Gynecologic Oncology, University of Palermo, Palermo, Italy.

T Marina (T)

Department of Gynecology, Valencian Institute of Oncology, Valencia, Spain.

J L Sánchez-Iglesias (JL)

Department of Obstetrics and Gynecology, Vall d'Hebron, Barcelona, Spain.

A Olloqui (A)

Department of Obstetrics and Gynecology, Hospital 12 de Octubre, Madrid, Spain.

Á García-Granero (Á)

Department of General Surgery, University Hospital La Fe, Valencia, Spain.

L Matute (L)

Department of Gynecologic Oncology Department, University Hospital La Fe, Valencia, Spain.

V Fornes (V)

Unit of Biostatistics, Health Research Institute Hospital La Fe, Valencia, Spain.

S Domingo (S)

Department of Gynecologic Oncology Department, University Hospital La Fe, Valencia, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH